Can RTX (RTX) Keep the Earnings Surprise Streak Alive? — Positive

RTX   Zacks Investment Research — April 10, 2026

RTX (RTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Can RTX (RTX) Keep the Earnings Surprise Streak Alive?

Will AudioEye (AEYE) Beat Estimates Again in Its Next Earnings Report? — Positive

AEYE   Zacks Investment Research — April 10, 2026

AudioEye (AEYE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will AudioEye (AEYE) Beat Estimates Again in Its Next Earnings Report?

Why Crocs (CROX) Could Beat Earnings Estimates Again — Positive

CROX   Zacks Investment Research — April 10, 2026

Crocs (CROX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Why Crocs (CROX) Could Beat Earnings Estimates Again

Will Booking Holdings (BKNG) Beat Estimates Again in Its Next Earnings Report? — Positive

BKNG   Zacks Investment Research — April 10, 2026

Booking Holdings (BKNG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Booking Holdings (BKNG) Beat Estimates Again in Its Next Earnings Report?

Will Carpenter (CRS) Beat Estimates Again in Its Next Earnings Report? — Positive

CRS   Zacks Investment Research — April 10, 2026

Carpenter (CRS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Carpenter (CRS) Beat Estimates Again in Its Next Earnings Report?

Will DigitalOcean (DOCN) Beat Estimates Again in Its Next Earnings Report? — Positive

DOCN   Zacks Investment Research — April 10, 2026

DigitalOcean (DOCN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will DigitalOcean (DOCN) Beat Estimates Again in Its Next Earnings Report?

Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? — Positive

ILMN   Zacks Investment Research — April 10, 2026

Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report?

Will Expedia (EXPE) Beat Estimates Again in Its Next Earnings Report? — Positive

EXPE   Zacks Investment Research — April 10, 2026

Expedia (EXPE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Expedia (EXPE) Beat Estimates Again in Its Next Earnings Report?

Will Citizens Financial Group (CFG) Beat Estimates Again in Its Next Earnings Report? — Positive

CFG   Zacks Investment Research — April 10, 2026

Citizens Financial Group (CFG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Citizens Financial Group (CFG) Beat Estimates Again in Its Next Earnings Report?

Will Cullen/Frost (CFR) Beat Estimates Again in Its Next Earnings Report? — Positive

CFR   Zacks Investment Research — April 10, 2026

Cullen/Frost (CFR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Cullen/Frost (CFR) Beat Estimates Again in Its Next Earnings Report?

Will Centerra Gold (CGAU) Beat Estimates Again in Its Next Earnings Report? — Positive

CGAU   Zacks Investment Research — April 10, 2026

Centerra Gold (CGAU) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Centerra Gold (CGAU) Beat Estimates Again in Its Next Earnings Report?

Anthropic is loving Nvidia right now and accelerating: Melius' Ben Reitzes — Positive

NVDA  P-ANTH   CNBC Television — April 10, 2026

Ben Reitzes, head of technology research at Melius Research, joins CNBC's "Money Movers" to discuss his latest price hike on Intel, artificial intelligence, and more.

image for news Anthropic is loving Nvidia right now and accelerating: Melius' Ben Reitzes

Will Chord Energy Corporation (CHRD) Beat Estimates Again in Its Next Earnings Report? — Positive

CHRD   Zacks Investment Research — April 10, 2026

Chord Energy Corporation (CHRD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Chord Energy Corporation (CHRD) Beat Estimates Again in Its Next Earnings Report?

Why Civista Bancshares (CIVB) Could Beat Earnings Estimates Again — Positive

CIVB   Zacks Investment Research — April 10, 2026

Civista Bancshares (CIVB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Why Civista Bancshares (CIVB) Could Beat Earnings Estimates Again

Will PennyMac Mortgage (PMT) Beat Estimates Again in Its Next Earnings Report? — Positive

PMT   Zacks Investment Research — April 10, 2026

PennyMac Mortgage (PMT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will PennyMac Mortgage (PMT) Beat Estimates Again in Its Next Earnings Report?

HF Foods: I Don't Buy Wall Street's Bull Case — Positive

HFFG   Seeking Alpha — April 10, 2026

HF Foods remains a 'Hold' as FY 2026 is projected to mirror FY 2025, with limited catalysts for upside. Significant dilution risk looms from a $100 million ATM program, potentially increasing shares outstanding if fully utilized. Management targets low single-digit revenue and EBITDA growth, with organic expansion and M&A constrained by high leverage (Debt/EBITDA > 4.5x).

image for news HF Foods: I Don't Buy Wall Street's Bull Case

KRISPY KREME® Makes Tax Day Sweeter with the Sweetest Tax Break — Neutral

DNUT   Business Wire — April 10, 2026

CHARLOTTE, N.C.--(BUSINESS WIRE)--After weeks of forms, filing, and final clicks of “submit,” Krispy Kreme® is giving Americans a well-earned reward for making it through tax season. For the fourth consecutive year, the brand is celebrating Tax Day by treating guests to one of the sweetest deals of the year, putting a sweet finish on a very grownup task that's not always the most fun task. On Wednesday, April 15 only, guests can mark “taxes done” by receiving a free Original Glazed® dozen when.

image for news KRISPY KREME® Makes Tax Day Sweeter with the Sweetest Tax Break

The red sea washing over Wall Street today has spared few, but for the discerning investor, the “AI infrastructure bloodbath” is exposing a critical rift between hype and durability. As inflation data comes in hotter than a cooling server rack, the “speculative froth” is evaporating from the edge computing and data sectors.

image for news AI infrastructure stocks sell-off: why NET and SNOW could be dip buys

BigBear.ai's Model-Agnostic AI Platform: A Competitive Edge? — Positive

BBAI   Zacks Investment Research — April 10, 2026

BBAI's model-agnostic platform, boosted by the late-2025 Ask Sage deal, targets defense users seeking flexible, secure AI without vendor lock-in.

image for news BigBear.ai's Model-Agnostic AI Platform: A Competitive Edge?

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200 — Positive

GILD  KYMR   Zacks Investment Research — April 10, 2026

Kymera Therapeutics secures $45M as Gilead licenses KT-200, advancing a novel CDK2 degrader with potential in breast cancer and solid tumors.

image for news KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200